Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 3/20 | 0.78 |
| ▸ | ALOX5 | P09917 | 8/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.63 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.63 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6475572 | 1.00 | PTGES (0.78) | PTGESALOX5PTGS1PTGS2ALOX5AP | |
| SCHEMBL9458734 | 0.92 | PTGES (0.65) | PTGESALOX5PTGS1PTGS2ALOX5AP | |
| SCHEMBL6487112 | 0.88 | PTGES (0.61) | PTGESALOX5PTGS1PTGS2ALOX5AP | |
| SCHEMBL6476339 | 0.81 | PTGES (0.65) | PTGESALOX5PTGS1PTGS2ALOX5AP | |
| Licofelone SCHEMBL237833 | 0.77 | ALOX5 (1.00) | PTGESALOX5PTGS1PTGS2ALOX5AP | |
| SCHEMBL8594214 | 0.77 | PTGES (0.74) | PTGESALOX5PTGS1 | |
| SCHEMBL6476356 | 0.76 | PTGES (0.58) | PTGESALOX5PTGS1PTGS2ALOX5AP | |
| SCHEMBL6485915 | 0.76 | PTGES (0.58) | PTGESALOX5PTGS1PTGS2ALOX5AP | |
| SCHEMBL6486937 | 0.76 | PTGES (0.58) | PTGESALOX5PTGS1 | |
| SCHEMBL6484148 | 0.76 | PTGES (0.58) | PTGESALOX5PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025245275-A1 | SURFACTANT PREPARATIONS FOR PULMONARY DELIVERY, AND METHODS FOR THE PREPARATION AND USE THEREOF | MOLECULAR EXPRESS, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| CN-115028695-B | Th1 and CTL epitope peptide pool based on LTBI-RD related protein and application thereof | 中国人民解放军总医院第八医学中心 | 2024-05-17 | — | — | CN | disclosed |
| EP-4226158-A1 | METHODS OF DIAGNOSING TUBERCULOSIS AND DIFFERENTIATING BETWEEN ACTIVE AND LATENT TUBERCULOSIS | Cepheid (US) | 2023-08-16 | — | — | EP | disclosed |
| CN-114736276-B | CTL epitope peptide of mycobacterium tuberculosis LTBI-RD related protein antigen and application thereof | 中国人民解放军总医院第八医学中心 | 2023-08-01 | — | — | CN | disclosed |
| CN-116348767-A | Method for diagnosing tuberculosis and distinguishing active tuberculosis from latent tuberculosis | 西菲伊德公司 | 2023-06-27 | — | — | CN | disclosed |
| WO-2022076428-A1 | METHODS OF DIAGNOSING TUBERCULOSIS AND DIFFERENTIATING BETWEEN ACTIVE AND LATENT TUBERCULOSIS | CEPHEID (US) | 2022-04-14 | — | — | WO | disclosed |
| US-20220106627-A1 | METHODS OF DIAGNOSING TUBERCULOSIS AND DIFFERENTIATING BETWEEN ACTIVE AND LATENT TUBERCULOSIS | CEPHEID (US) | 2022-04-07 | — | — | US | disclosed |
| EP-1246825-B1 | FUSED PYRROLE COMPOUNDS, PHARMACEUTICAL AGENTS CONTAINING THE SAME, AND THE USE THEREOF | MERCKLE GMBH (DE) | 2003-12-17 | — | — | EP | disclosed |